Skip to main content
Erschienen in: Journal of Neural Transmission 6/2013

01.06.2013 | Translational Neurosciences - Original Article

Arterial vascular cell line expressing SSAO: a new tool to study the pathophysiology of vascular amine oxidases

verfasst von: Kaleem Ullah, Bingjie Xie, Javed Iqbal, Aamir Rasool, Hong Qing, Yulin Deng

Erschienen in: Journal of Neural Transmission | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Semicarbazide-sensitive amine oxidase (SSAO) widely exists in nature, mainly expressed at significant levels in vasculature. It plays a detrimental role in vascular diseases, particularly atherosclerosis, which occurs mainly in arteries. Herein we for the first time present SSAO expression in arterial lineage of vascular cell line, i.e., human umbilical arterial endothelial cell (HUAEC). Firstly, two commercially available gene transfection reagents were compared to determine high transfection efficiency and then the expression behavior of HUAEC:SSAO was characterized. Furthermore, our model was also been compared with commonly used human embryonic kidney (HEK) cell transfected with the same vector. For enzymatic assay, an in-house developed highly sensitive high performance liquid chromatography electron spray ionization mass spectrometry method was applied. Results indicated that the maximal transfection efficiency in HUAEC was detected by JetPEI™ and transfected protein was expressed at membrane and cytosol of different clones. No significant variations were observed in HUAEC between cell passages 1 and 7, although HEK cell displayed twofold higher SSAO expression level than HUAEC. The transfected SSAO was shown to be released into the cell-culture medium. Both cellular and released types of SSAO exhibited monomer and dimer structural forms. The cytotoxicity determination exhibited large number of viable cells after transfection with JetPEI™. Differential expression characterization of this new cell line demonstrates the correct behavior of SSAO in arterial endothelial cells and also provides a real physiological environment to elucidate the unclear role of this enzyme. In addition, our cellular model could partly solve the problems raised by the loss of enzyme expression found in cultured endothelial cells. This model could also be a useful tool for proteomic base study, screening of interacting protein and analysis of compounds that could modify its activity for therapeutic purposes.
Literatur
Zurück zum Zitat Andres N, Lizcano JM, Rodriguez MJ, Romera M, Unzeta M, Mahy N (2001) Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase. J Histochem Cytochem (Off J Histochem Soc) 49(2):209–217CrossRef Andres N, Lizcano JM, Rodriguez MJ, Romera M, Unzeta M, Mahy N (2001) Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase. J Histochem Cytochem (Off J Histochem Soc) 49(2):209–217CrossRef
Zurück zum Zitat Boomsma F, Derkx FH, van den Meiracker AH, Man in ‘t Veld AJ, Schalekamp MA (1995) Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci (London) 88(6):675–679 Boomsma F, Derkx FH, van den Meiracker AH, Man in ‘t Veld AJ, Schalekamp MA (1995) Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci (London) 88(6):675–679
Zurück zum Zitat Boomsma F, van Veldhuisen DJ, de Kam PJ, Man in ‘t Veld AJ, Mosterd A, Lie KI, Schalekamp MA (1997) Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res 33(2):387–391PubMedCrossRef Boomsma F, van Veldhuisen DJ, de Kam PJ, Man in ‘t Veld AJ, Mosterd A, Lie KI, Schalekamp MA (1997) Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res 33(2):387–391PubMedCrossRef
Zurück zum Zitat Camos S, Mallolas J (2010) Experimental models for assaying microvascular endothelial cell pathophysiology in stroke. Molecules 15(12):9104–9134PubMedCrossRef Camos S, Mallolas J (2010) Experimental models for assaying microvascular endothelial cell pathophysiology in stroke. Molecules 15(12):9104–9134PubMedCrossRef
Zurück zum Zitat Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91(10):3527–3561PubMed Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91(10):3527–3561PubMed
Zurück zum Zitat Conklin DJ, Langford SD, Boor PJ (1998) Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity. Toxicol Sci (Off J Soc Toxicol) 46(2):386–392. doi:10.1006/toxs.1998.2528 CrossRef Conklin DJ, Langford SD, Boor PJ (1998) Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity. Toxicol Sci (Off J Soc Toxicol) 46(2):386–392. doi:10.​1006/​toxs.​1998.​2528 CrossRef
Zurück zum Zitat Creager MA, Luscher TF, Cosentino F, Beckman JA (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 108(12):1527–1532PubMedCrossRef Creager MA, Luscher TF, Cosentino F, Beckman JA (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 108(12):1527–1532PubMedCrossRef
Zurück zum Zitat del Mar Hernandez M, Esteban M, Szabo P, Boada M, Unzeta M (2005) Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging. Neurosci Lett 384(1–2):183–187PubMedCrossRef del Mar Hernandez M, Esteban M, Szabo P, Boada M, Unzeta M (2005) Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging. Neurosci Lett 384(1–2):183–187PubMedCrossRef
Zurück zum Zitat Florea BI, Meaney C, Junginger HE, Borchard G (2002) Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures. AAPS Pharm Sci 4(3):E12CrossRef Florea BI, Meaney C, Junginger HE, Borchard G (2002) Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures. AAPS Pharm Sci 4(3):E12CrossRef
Zurück zum Zitat Gokturk C, Garpenstrand H, Nilsson J, Nordquist J, Oreland L, Forsberg-Nilsson K (2003) Studies on semicarbazide-sensitive amine oxidase in patients with diabetes mellitus and in transgenic mice. Biochim Biophys Acta 1647(1–2):88–91PubMed Gokturk C, Garpenstrand H, Nilsson J, Nordquist J, Oreland L, Forsberg-Nilsson K (2003) Studies on semicarbazide-sensitive amine oxidase in patients with diabetes mellitus and in transgenic mice. Biochim Biophys Acta 1647(1–2):88–91PubMed
Zurück zum Zitat Hernandez-Guillamon M, Garcia-Bonilla L, Sole M, Sosti V, Pares M, Campos M, Ortega-Aznar A, Dominguez C, Rubiera M, Ribo M, Quintana M, Molina CA, Alvarez-Sabin J, Rosell A, Unzeta M, Montaner J (2010) Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke. Stroke (J Cereb Circ) 41(7):1528–1535CrossRef Hernandez-Guillamon M, Garcia-Bonilla L, Sole M, Sosti V, Pares M, Campos M, Ortega-Aznar A, Dominguez C, Rubiera M, Ribo M, Quintana M, Molina CA, Alvarez-Sabin J, Rosell A, Unzeta M, Montaner J (2010) Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke. Stroke (J Cereb Circ) 41(7):1528–1535CrossRef
Zurück zum Zitat Jaakkola K, Kaunismaki K, Tohka S, Yegutkin G, Vanttinen E, Havia T, Pelliniemi LJ, Virolainen M, Jalkanen S, Salmi M (1999) Human vascular adhesion protein-1 in smooth muscle cells. Am J Pathol 155(6):1953–1965PubMedCrossRef Jaakkola K, Kaunismaki K, Tohka S, Yegutkin G, Vanttinen E, Havia T, Pelliniemi LJ, Virolainen M, Jalkanen S, Salmi M (1999) Human vascular adhesion protein-1 in smooth muscle cells. Am J Pathol 155(6):1953–1965PubMedCrossRef
Zurück zum Zitat Johnson AR (1980) Human pulmonary endothelial cells in culture. Activities of cells from arteries and cells from veins. J Clin Investig 65(4):841–850PubMedCrossRef Johnson AR (1980) Human pulmonary endothelial cells in culture. Activities of cells from arteries and cells from veins. J Clin Investig 65(4):841–850PubMedCrossRef
Zurück zum Zitat Langford SD, Trent MB, Balakumaran A, Boor PJ (1999) Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase. Toxicol Appl Pharmacol 155(3):237–244PubMedCrossRef Langford SD, Trent MB, Balakumaran A, Boor PJ (1999) Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase. Toxicol Appl Pharmacol 155(3):237–244PubMedCrossRef
Zurück zum Zitat Madej A, Reich A, Orda A, Szepietowski JC (2007) Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients. J Eur Acad Dermatol Venereol (JEADV) 21(1):72–78CrossRef Madej A, Reich A, Orda A, Szepietowski JC (2007) Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients. J Eur Acad Dermatol Venereol (JEADV) 21(1):72–78CrossRef
Zurück zum Zitat Mateo T, Naim Abu Nabah Y, Losada M, Estelles R, Company C, Bedrina B, Cerda-Nicolas JM, Poole S, Jose PJ, Cortijo J, Morcillo EJ, Sanz MJ (2007) A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles. Blood 110(6):1895–1902PubMedCrossRef Mateo T, Naim Abu Nabah Y, Losada M, Estelles R, Company C, Bedrina B, Cerda-Nicolas JM, Poole S, Jose PJ, Cortijo J, Morcillo EJ, Sanz MJ (2007) A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles. Blood 110(6):1895–1902PubMedCrossRef
Zurück zum Zitat Mercier N (2009) The role of semicarbazide-sensitive amine oxidase in the arterial wall. Artery Res 3(4):141–147CrossRef Mercier N (2009) The role of semicarbazide-sensitive amine oxidase in the arterial wall. Artery Res 3(4):141–147CrossRef
Zurück zum Zitat Meszaros Z, Karadi I, Csanyi A, Szombathy T, Romics L, Magyar K (1999) Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis. Eur J Drug Metab Pharmacokinet 24(4):299–302PubMedCrossRef Meszaros Z, Karadi I, Csanyi A, Szombathy T, Romics L, Magyar K (1999) Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis. Eur J Drug Metab Pharmacokinet 24(4):299–302PubMedCrossRef
Zurück zum Zitat Nemcsik J, Szoko E, Soltesz Z, Fodor E, Toth L, Egresits J, Tabi T, Magyar K, Kiss I (2007) Alteration of serum semicarbazide-sensitive amine oxidase activity in chronic renal failure. J Neural Transm 114(6):841–843PubMedCrossRef Nemcsik J, Szoko E, Soltesz Z, Fodor E, Toth L, Egresits J, Tabi T, Magyar K, Kiss I (2007) Alteration of serum semicarbazide-sensitive amine oxidase activity in chronic renal failure. J Neural Transm 114(6):841–843PubMedCrossRef
Zurück zum Zitat Nunes SF, Figueiredo IV, Pereira JS, de Lemos ET, Reis F, Teixeira F, Caramona MM (2011) Monoamine oxidase and semicarbazide-sensitive amine oxidase kinetic analysis in mesenteric arteries of patients with type 2 diabetes. Physiol Res (Academia Scientiarum Bohemoslovaca) 60(2):309–315 Nunes SF, Figueiredo IV, Pereira JS, de Lemos ET, Reis F, Teixeira F, Caramona MM (2011) Monoamine oxidase and semicarbazide-sensitive amine oxidase kinetic analysis in mesenteric arteries of patients with type 2 diabetes. Physiol Res (Academia Scientiarum Bohemoslovaca) 60(2):309–315
Zurück zum Zitat Obata T (2006) Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review. Life Sci 79(5):417–422PubMedCrossRef Obata T (2006) Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review. Life Sci 79(5):417–422PubMedCrossRef
Zurück zum Zitat O’Sullivan J, Unzeta M, Healy J, O’Sullivan MI, Davey G, Tipton KF (2004) Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do. Neurotoxicology 25(1–2):303–315PubMedCrossRef O’Sullivan J, Unzeta M, Healy J, O’Sullivan MI, Davey G, Tipton KF (2004) Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do. Neurotoxicology 25(1–2):303–315PubMedCrossRef
Zurück zum Zitat Salmi M, Jalkanen S (1992) A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257(5075):1407–1409PubMedCrossRef Salmi M, Jalkanen S (1992) A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257(5075):1407–1409PubMedCrossRef
Zurück zum Zitat Sole M, Unzeta M (2011) Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases. Biol Cell (under the auspices of the European Cell Biology Organization) 103(11):543–557. doi:10.1042/BC20110049 CrossRef Sole M, Unzeta M (2011) Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases. Biol Cell (under the auspices of the European Cell Biology Organization) 103(11):543–557. doi:10.​1042/​BC20110049 CrossRef
Zurück zum Zitat Sole M, Hernandez M, Boada M, Unzeta M (2007) Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line). J Neural Transm 114(6):763–767PubMedCrossRef Sole M, Hernandez M, Boada M, Unzeta M (2007) Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line). J Neural Transm 114(6):763–767PubMedCrossRef
Zurück zum Zitat Stolen CM, Yegutkin GG, Kurkijarvi R, Bono P, Alitalo K, Jalkanen S (2004) Origins of serum semicarbazide-sensitive amine oxidase. Circ Res 95(1):50–57PubMedCrossRef Stolen CM, Yegutkin GG, Kurkijarvi R, Bono P, Alitalo K, Jalkanen S (2004) Origins of serum semicarbazide-sensitive amine oxidase. Circ Res 95(1):50–57PubMedCrossRef
Zurück zum Zitat Szasz T, Thakali K, Fink GD, Watts SW (2007) A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Exp Biol Med (Maywood) 232(1):27–37 Szasz T, Thakali K, Fink GD, Watts SW (2007) A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease. Exp Biol Med (Maywood) 232(1):27–37
Zurück zum Zitat Wang L, Zhang Y, Xiao S, Hu G, Che B, Qing H, Li Y, Zhuang L, Deng Y (2012) LC–MS method for determining the activity of semicarbazide-sensitive amine oxidase in rodents. Anal Methods 4(5):1383–1388CrossRef Wang L, Zhang Y, Xiao S, Hu G, Che B, Qing H, Li Y, Zhuang L, Deng Y (2012) LC–MS method for determining the activity of semicarbazide-sensitive amine oxidase in rodents. Anal Methods 4(5):1383–1388CrossRef
Zurück zum Zitat Yu PH, Zuo DM (1993) Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes 42(4):594–603PubMedCrossRef Yu PH, Zuo DM (1993) Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes 42(4):594–603PubMedCrossRef
Metadaten
Titel
Arterial vascular cell line expressing SSAO: a new tool to study the pathophysiology of vascular amine oxidases
verfasst von
Kaleem Ullah
Bingjie Xie
Javed Iqbal
Aamir Rasool
Hong Qing
Yulin Deng
Publikationsdatum
01.06.2013
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 6/2013
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-013-1015-z

Weitere Artikel der Ausgabe 6/2013

Journal of Neural Transmission 6/2013 Zur Ausgabe

Neurology and Preclinical Neurological Studies - Original Article

New tools for studying old questions: antibodies for human diamine oxidase

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.